alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,301–3,325 of 27,380 studies, newest first · page 133 of 1096.

September 2025 25

  1. 2025-09-01

    Cardiometabolic disorders and mild cognitive impairment in White and Black Americans

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia

    Key finding: Controlling for demographic/health variables, individuals with aMCI, though not naMCI, showed a higher likelihood of hypertension, diabetes, and hyperlipidemia compared to cognitively normal counterparts, though no differences between aMCI/naMCI. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2025-09-01

    Impact of cardiometabolic conditions on the progression from mild cognitive impairment to dementia: A large cohort study

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia

    Key finding: During a 7-year median follow-up, type 2 diabetes was associated with the highest risk of all-cause dementia (hazard ratio [HR] 1.18, 95% confidence interval [CI]: 1.06 to 1.31), followed by hypertension and hyperlipidemia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2025-09-01

    Co‐pathology in Alzheimer's disease and Lewy body disease and its association with neuropsychiatric symptoms

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Co-existing neuropathology was frequent, even among individuals without clinical dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2025-09-01

    Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants

    ✓ Peer-reviewed Lewy body dementia European Journal of Neurology

    Key finding: At baseline, sbvFTD showed right-predominant temporal pole involvement associated with significant right frontal atrophy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2025-09-01

    Neural Basis of Anxiety in Dementia With Lewy Bodies

    ✓ Peer-reviewed Lewy body dementia International Journal of Geriatric Psychiatry

    Key finding: Patients with DLB with anxiety had a significantly higher percentage of fluctuating cognition than those without anxiety. +3 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2025-09-01

    Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype‐specific, and severity‐linked alterations

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: FTD subjects exhibited increased plasma levels of gangliosides (GM3(d18:1_16:0), GM3(d18:1_24:1)), ceramide Cer(d18:1_23:0), and select polyunsaturated triacylglycerols. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2025-09-01

    Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorder

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Phenoconverters had higher FW in the NBM and posterior SN. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2025-09-01

    Recent advances in neuroimaging of Alzheimer's disease and related dementias

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: HIGHLIGHTS: The diagnostic and staging criteria for Alzheimer's disease (AD) were updated in 2024. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2025-09-01

    Association Between Plasma Metabolomic Profile and Machine Learning‐Based Brain Age

    ✓ Peer-reviewed Digital health tools Aging Cell

    Key finding: Metabolomics has been associated with cognitive decline and dementia, but the relationship between metabolites and brain aging remains unclear. +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2025-09-01

    An AI‐first framework for multimodal data in Alzheimer's disease and related dementias

    ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia

    Key finding: HIGHLIGHTS: Understanding and managing ADRD requires integrating biological, cognitive, and behavioral data across multiple modalities. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2025-09-01

    Retinal biomarkers in cognitive impairment and dementia: Structural, functional, and molecular insights

    ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia

    Key finding: Nevertheless, translating biomarkers into clinical practice faces significant translational hurdles, including methodological heterogeneity, confounding variables, lack of standardized protocols, and insufficient longitudinal validation in diverse populations.

    Full summary, score breakdown and related studies → Original source

  12. 2025-09-01

    Artificial intelligence approach to optimise safety for hospitalised patients with dementia

    ✓ Peer-reviewed Digital health tools BMJ Open Quality

    Key finding: We used 1387 safety event reports for model development, 989 (71.3%) reports related to situational factors and 119 (8.6%) reports related to active failures. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2025-09-01

    Prevalence and co-occurrence of dementia risk factors in Denmark: A nationwide study

    ✓ Peer-reviewed How common it is The Journal of Prevention of Alzheimer s Disease

    Key finding: In the whole population (N = 1,214,286) and the subpopulation (N = 88,565), 5 % had no risk factors, 12 % had only one, and 82 % had multiple. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2025-09-01

    Neuroimaging markers of dementia across race/ethnicity and sex/gender using an intersectional approach within the HABS‐HD cohort

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia

    Key finding: We analyzed data from 3433 dementia-free participants with either magnetic resonance imaging or positron emission tomography (PET) data at baseline (mean [standard deviation] age: 65 [9] years, 36% non-Hispanic White [NHW], 27% Black, 37% Hispanic, and 63% women). +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2025-09-01

    Smartphone App-Based Psychoeducation for Caregivers of People with Dementia in Vietnam: A Pilot Randomized Controlled Trial

    ✓ Peer-reviewed Caregiving Clinical Interventions in Aging

    Key finding: Of the 62 caregivers approached, 60 enrolled (96.7%), and 54 completed the study (90% retention). +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2025-09-01

    ALZHEIMER E A EVOLUÇÃO DO TRATAMENTO NA ÚLTIMA DÉCADA: UMA REVISÃO DE LITERATURA

    ✓ Peer-reviewed Treatments JNT - Facit Business and Technology Journal

    Key finding: Os resultados demonstraram que p tratamento do Alzheimer avança além das terapias sintomáticas atuais, focando em estratégias modificadoras da doença. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2025-09-01

    ALZHEIMER E A EVOLUÇÃO DO TRATAMENTO NA ÚLTIMA DÉCADA: UMA REVISÃO DE LITERATURA

    ✓ Peer-reviewed Treatments JNT - Facit Business and Technology Journal

    Key finding: Os resultados demonstraram que p tratamento do Alzheimer avança além das terapias sintomáticas atuais, focando em estratégias modificadoras da doença. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2025-09-01

    Netzwerkmetaanalyse zu neuen Therapieoptionen bei Alzheimer Demenz

    ✓ Peer-reviewed Treatments Fortschritte der Neurologie · Psychiatrie

    Key finding: Mit der Zulassung von Lecanemab in Europa ist die Antikörpertherapie bei Alzheimer Krankheit (AD) hierzulande angekommen. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2025-09-01

    ApoE4 Upregulates GSK ‐3β to Aggravate Alzheimer‐Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice

    ✓ Peer-reviewed Genetics CNS Neuroscience & Therapeutics

    Key finding: We observed that GSK-3β activity was significantly upregulated in ApoE4 mice, accompanied by disruption of the insulin signaling pathway. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2025-09-01

    [An Overview of Medical Fees and Patient Cost-Sharing in Dementia Care in Japan]

    ✓ Peer-reviewed Health systems and care delivery No shinkei geka. Neurological surgery

    Key finding: In Japan, dementia-related medical services are covered by the universal health insurance system, with patient co-payments based on age and income. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2025-09-01

    Awareness and Working Intentions Toward Home-Based Care Among Macau Nurses

    ✓ Peer-reviewed Health systems and care delivery Home Healthcare Now

    Key finding: This study found that awareness of home-based nursing, interest in home-based care for older people, and attitudes toward filial responsibility significantly influence the intention to work in home-based care. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2025-09-01

    The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach

    ✓ Peer-reviewed Risk factors Journal of Alzheimer s Disease

    Key finding: Significant regional differences in AD dementia prevalence were observed (F = 126.56, p < 0.05). +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2025-09-01

    Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

    ✓ Peer-reviewed Tau biomarkers Clinical nuclear medicine

    Key finding: Alzheimer disease (AD) is characterized by amyloid-β plaques (A), tau tangles (T), and neurodegeneration (N), collectively defining the ATN framework. +3 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2025-09-01

    Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: The use of region-level PM may have systematically biased the estimated associations with Alzheimer disease (AD).ObjectiveTo obtain pilot data on person-specific digital measurements of exposure to PM and volatile organic compounds (VOC) and to correlate them with AD biomarkers, including plasma and cerebrospinal fluid (CSF) analytes and amyloid and tau positron emission tomography (PET) signal, and to generate hypotheses about these correlations. +3 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2025-09-01

    Arterial stiffness and vascular aging: mechanisms, prevention, and therapy

    ✓ Peer-reviewed Prevention and risk Signal transduction and targeted therapy

    Key finding: Current research indicates that arterial stiffness is an independent risk factor for cardiovascular diseases and represents a potential target for personalized prevention and therapeutic approaches.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →